The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
Abstract
Abstract:Clostridium difficile is diagnosed using the enzyme-linked immunoassay (EIA) with the specificity and sensitivity ranging from 50–90% and 70–95%, respectively. Due to the wide ranges, there is considerable confusion regarding the value of the EIA toxin test. We undertook this study to evaluate the benefit of repeat stool toxin testing.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Bartlett JG, Chang TW, Gurwith M, et al. Antibiotic-associated pseudo membranous colitis due to toxin-producing clostridia. N Engl J Med 1978;298:531–534.BartlettJG]]ChangTW]]GurwithM&etal;Antibiotic-associated pseudo membranous colitis due to toxin-producing clostridia.N Engl J Med1978298531-5342. Bartlett JG. Clostridium difficile: clinical considerations. Rev Infect Dis 1990;12(suppl 2):S243–S251.BartlettJGClostridium difficile: clinical considerations.Rev Infect Dis199012S243-S2513. Gronczewski C. Clostridium difficile colitis. Available at: Emedicine.com. Accessed May 17, 2007.4. Miller MA, Hyland M, Ofner M, et al. The Canadian Hospital Epidemiology Committee, and the Canadian Nosocomial Infection Surveillance Program, Health Canada Morbidity, Mortality, and Health-Care Burden of Nosocomial Clostridium difficile-Associated Diarrhea in Canadian Hospitals 8 th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1998;19:691.MillerMA]]HylandM]]OfnerM&etal;The Canadian Hospital Epidemiology Committee, and the Canadian Nosocomial Infection Surveillance Program, Health Canada Morbidity, Mortality, and Health-Care Burden of Nosocomial Clostridium difficile-Associated Diarrhea in Canadian Hospitals 8 th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America.Infect Control Hosp Epidemiol1998196915. Manabe Y, Vinetz J, Moore R, et al. Clostridium difficile colitis: a n efficient clinical approach to diagnosis. Ann Intern Med 1995;123:835–840.ManabeY]]VinetzJ]]MooreR&etal;Clostridium difficile colitis: a n efficient clinical approach to diagnosis.Ann Intern Med1995123835-8406. Thibault A, Miller MA, Gaese C. Risk factors for the development of Clostridium difficile associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol 1991;12:34–348.ThibaultA]]MillerMA]]GaeseCRisk factors for the development of Clostridium difficile associated diarrhea during a hospital outbreak.Infect Control Hosp Epidemiol19911234-3487. Brown E, Talbot GH, Axelrod P, et al. Risk factors for Clostridium difficile toxin associated diarrhea. Infect Control Hosp Epidemiol 1990;11:283–290.BrownE]]TalbotGH]]AxelrodP&etal;Risk factors for Clostridium difficile toxin associated diarrhea.Infect Control Hosp Epidemiol199011283-2908. Mohan S, McDermott B, Parchuri S, et al. Lack of value of repeat stool testing for Clostridium difficile toxin. Am J Med 2006;119:356.e7–356.e8.MohanS]]McDermottB]]ParchuriS&etal;Lack of value of repeat stool testing for Clostridium difficile toxin.Am J Med2006119356.e7-356.e89. Starr J. Clostridium difficile associated diarrhea: diagnosis and treatment. BMJ 2005;331:498–501.StarrJClostridium difficile associated diarrhea: diagnosis and treatment.BMJ2005331498-50110. Renshaw AA, Stelling JM, Doolittle M. The lack of value of repeated Clostridium difficile cytotoxic assays. Arch Pathol Lab Med 1996;120:49–52.RenshawAA]]StellingJM]]DoolittleMThe lack of value of repeated Clostridium difficile cytotoxic assays.Arch Pathol Lab Med199612049-5211. Weitzel T, Schnabel E, Dieckmann S, et al. Evaluation of a new point-of-care test for influenza A and B virus in travelers with influenza-like symptoms. Clin Microbiol Infect 2007;13:665–669.WeitzelT]]SchnabelE]]DieckmannS&etal;Evaluation of a new point-of-care test for influenza A and B virus in travelers with influenza-like symptoms.Clin Microbiol Infect200713665-66912. Laga EA Jr, Toth BB, Rolston KV. Evaluation of a rapid enzyme-linked immunoassay for the diagnosis of herpes simplex virus in cancer patients with oral lesions. Oral Surg Oral Med Oral Pathol 1993;75:168–172.LagaEAJr]]TothBB]]RolstonKVEvaluation of a rapid enzyme-linked immunoassay for the diagnosis of herpes simplex virus in cancer patients with oral lesions.Oral Surg Oral Med Oral Pathol199375168-172
